Welcome to the Bioasis Technologies Hub On AGORACOM
Discovery of a Highly Conserved Peptide in the Iron Transporter Melanotransferrin that Traverses an Intact Blood Brain Barrier and Localizes in Neural Cells
A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
BiOasis Sept 2015 Nature BioPharma Dealmakers
BiOasis in September 2015 issue of Nature BioPharma Dealmakers. Click on "read the latest issue" to browse to page B7 or scroll down and click on the BiOasis company profile link.
biOasis to file IND for HER2+ brain cancer treatment in 2016
biOasis Enters Into a Collaborative Research and Joint Funding Support Agreement Entitled “Focus on Brain”
biOasis today announces that it, in partnership with the National Research Council of Canada and the Université de Sherbrooke, has been awarded a collaborative research grant by the CQDM and Brain Canada. In their “Focus on Brain” call for proposals, the partners received a number of applications from companies and academic institutions. The focus of the research agreement is to identify a new generation of potential blood-brain barrier (BBB) carrier molecules.
biOasis Enters Into a Collaborative Research and Joint Funding Support Agreement
biOasis today announces that it, in partnership with the National Research Council of Canada and the Université de Sherbrooke, has been awarded a collaborative research grant by the CQDM and Brain Canada. In their “Focus on Brain” call for proposals, the partners received a number of applications from companies and academic institutions. The focus of the research agreement is to identify a new generation of potential blood-brain barrier (BBB) carrier molecules.